Probing nanoparticle translocation across the permeable endothelium in experimental atherosclerosis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 3, 2014, Pages 1078-1083

  Kim, Yongtae ^a   Lobatto, Mark E ^b,c   Kawahara, Tomohiro ^d   Chung, Bomy Lee ^e,f   Mieszawska, Aneta J ^b   Sanchez Gaytan, Brenda L ^b   Fay, Francois ^b   Senders, Max L ^b   Calcagno, Claudia ^b   Becraft, Jacob ^f   Saung, May Tun ^e   Gordon, Ronald E ^g   Stroes, Erik S G ^c   Ma, Mingming ^e   Farokhzad, Omid C ^h   Fayad, Zahi A ^b   Mulder, Willem J M ^b,c   Langer, Robert ^e,f,i  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d KYUSHU INSTITUTE OF TECHNOLOGY   (Japan)

^e MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^f Massachusetts Institute of Technology Cambridge   (United States)

^g BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h MOUNT SINAI HOSPITAL   (United States)

ⁱ BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Cardiovascular disease; Microfluidics; Nanotechnology; Noninvasive imaging

Indexed keywords

LIPID; NANOPARTICLE; POLYMER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL STRUCTURE; CONTROLLED STUDY; ENDOTHELIUM; ENDOTHELIUM CELL; EXPERIMENTAL ATHEROSCLEROSIS; FLUORESCENCE IMAGING; HUMAN; HUMAN CELL; HYBRID; IMAGING SYSTEM; IN VITRO STUDY; IN VIVO STUDY; MALE; MECHANICAL PROBE; MICROCHIP ANALYSIS; MICROFLUIDICS; NONHUMAN; PRIORITY JOURNAL; RABBIT MODEL; WHOLE BODY SCANNER;

CARDIOVASCULAR DISEASE; MICROFLUIDICS; NANOTECHNOLOGY; NONINVASIVE IMAGING;

ANIMALS; ATHEROSCLEROSIS; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; ENDOTHELIUM; GOLD; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; METAL NANOPARTICLES; MICROCIRCULATION; MICROFLUIDICS; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, FLUORESCENCE; MODELS, THEORETICAL; PERMEABILITY; PLAQUE, ATHEROSCLEROTIC; RABBITS; SHEAR STRENGTH;

EID: 84892921738     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1322725111     Document Type: Article

References (34)

1. Petros RA, DeSimone JM (2010) Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov 9(8):615-627.
2. Farokhzad OC, Langer R (2009) Impact of nanotechnology on drug delivery. ACS Nano 3(1):16-20.
3. Crielaard BJ, Lammers T, Schiffelers RM, Storm G (2012) Drug targeting systems for inflammatory disease: One for all, all for one. J Control Release 161(2):225-234.
4. Lobatto ME, Fuster V, Fayad ZA, Mulder WJ (2011) Perspectives and opportunities for nanomedicine in the management of atherosclerosis. Nat Rev Drug Discov 10(11):835-852.
5. Peer D, et al. (2007) Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2(12):751-760.
6. Schroeder A, et al. (2012) Treating metastatic cancer with nanotechnology. Nat Rev Cancer 12(1):39-50.
7. Prabhakar U, et al. (2013) Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology. Cancer Res 73(8):2412-2417.
8. Chauhan VP, et al. (2012) Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner. Nat Nanotechnol 7(6):383-388.
9. Danquah MK, Zhang XA, Mahato RI (2011) Extravasation of polymeric nanomedicines across tumor vasculature. Adv Drug Deliv Rev 63(8):623-639.
10. Godin B, et al. (2010) Emerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseases. Trends Pharmacol Sci 31(5):199-205.
11. Granada JF, Feinstein SB (2008) Imaging of the vasa vasorum. Nat Clin Pract Cardiovasc Med 5(Suppl 2):S18-S25.
12. Sanhai WR, Sakamoto JH, Canady R, Ferrari M (2008) Seven challenges for nanomedicine. Nat Nanotechnol 3(5):242-244.
13. Sanz J, Fayad ZA (2008) Imaging of atherosclerotic cardiovascular disease. Nature 451(7181):953-957.
14. Nguyen DH, et al. (2013) Biomimetic model to reconstitute angiogenic sprouting morphogenesis in vitro. Proc Natl Acad Sci USA 110(17):6712-6717.
15. Bischel LL, Young EW, Mader BR, Beebe DJ (2013) Tubeless microfluidic angiogenesis assay with three-dimensional endothelial-lined microvessels. Biomaterials 34(5):1471-1477.
16. Zheng Y, et al. (2012) In vitro microvessels for the study of angiogenesis and thrombosis. Proc Natl Acad Sci USA 109(24):9342-9347.
17. Borenstein JT, et al. (2010) Functional endothelialized microvascular networks with circular cross-sections in a tissue culture substrate. Biomed Microdevices 12(1):71-79.
18. Tsai M, et al. (2012) In vitro modeling of the microvascular occlusion and thrombosis that occur in hematologic diseases using microfluidic technology. J Clin Invest 122(1):408-418.
19. Ernsting MJ, Murakami M, Roy A, Li SD (2013) Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles. J Control Release 172(3):782-794.
20. Kleinbongard P, Heusch G, Schulz R (2010) TNFalpha in atherosclerosis, myocardial ischemia/reperfusion and heart failure. Pharmacol Ther 127(3):295-314.
21. Sattar N, McCarey DW, Capell H, McInnes IB (2003) Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 108(24):2957-2963.
22. Schlitt A, et al. (2004) CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-alpha levels. Thromb Haemost 92(2):419-424.
23. Kim Y, et al. (2012) Mass production and size control of lipid-polymer hybrid nanoparticles through controlled microvortices. Nano Lett 12(7):3587-3591.
24. Mieszawska AJ, et al. (2013) Synthesis of polymer-lipid nanoparticles for imageguided delivery of dual modality therapy. Bioconjug Chem 24(9):1429-1434.
25. Chiu JJ, Chien S (2011) Effects of disturbed flow on vascular endothelium: Pathophysiological basis and clinical perspectives. Physiol Rev 91(1):327-387.
26. Malek AM, Alper SL, Izumo S (1999) Hemodynamic shear stress and its role in atherosclerosis. JAMA 282(21):2035-2042.
27. Lobatto ME, et al. (2012) Imaging the efficacy of anti-inflammatory liposomes in a rabbit model of atherosclerosis by non-invasive imaging. Methods Enzymol 508:211-228.
28. Tarbell JM (2010) Shear stress and the endothelial transport barrier. Cardiovasc Res 87(2):320-330.
29. Moreno PR, Purushothaman KR, Sirol M, Levy AP, Fuster V (2006) Neovascularization in human atherosclerosis. Circulation 113(18):2245-2252.
30. Qin D, Xia Y, Whitesides GM (2010) Soft lithography for micro- and nanoscale patterning. Nat Protoc 5(3):491-502.
31. Aran K, Sasso LA, Kamdar N, Zahn JD (2010) Irreversible, direct bonding of nanoporous polymer membranes to PDMS or glass microdevices. Lab Chip 10(5):548-552.
32. Khan OF, Sefton MV (2011) Endothelial cell behaviour within a microfluidic mimic of the flow channels of a modular tissue engineered construct. Biomed Microdevices 13(1):69-87.
33. Mieszawska AJ, et al. (2012) Engineering of lipid-coated PLGA nanoparticles with a tunable payload of diagnostically active nanocrystals for medical imaging. Chem Commun (Camb) 48(47):5835-5837.
34. Calcagno C, et al. (2008) Detection of neovessels in atherosclerotic plaques of rabbits using dynamic contrast enhanced MRI and 18F-FDG PET. Arterioscler Thromb Vasc Biol 28(7):1311-1317.